KOPPERS REPORTS SECOND QUARTER 2026 RESULTS

Koppers posted Q2 2026 net sales of $520.1M (+3.0% y/y), but a GAAP net loss of $(147.5)M driven by $215.8M of impairment, restructuring and plant-closure costs; diluted EPS was $(7.71) vs. $0.81. Adjusted EPS fell to $1.37 (-7.4% y/y) and adjusted EBITDA slipped to $71.0M (-7.9% y/y), though cash flow improved sharply with record operating cash flow of $96.3M and free cash flow of $72.6M for the first six months. Management guided that the tougher margin environment will persist through 2H26, with 2026 adjusted EPS at $3.80–$4.20 (below prior $3.80–$4.60) while emphasizing continued debt reduction and capital returns.

Analysis

The operative issue is not the headline loss; it is that Koppers is effectively telling you end-market pricing is still too weak to outrun inflation in freight/raw materials, and the “good” cash flow is partly a working-capital harvest that may not repeat at the same rate. That combination usually means the equity can rally on non-cash impairment optics, but the multiple should stay pinned until investors see sustained margin rebuild in RUPS and CMC rather than one-time cash conversion.

Second-order, the plant closure and network optimization are capacity rationalizations that should eventually help the cleaner operators in treated wood and carbon intermediates by removing some supply, but the near-term effect is more likely lost volume than pricing power for KOP. If utilization fails to recover, the company’s fixed-cost absorption problem will keep turning modest pricing pressure into outsized EBITDA volatility, which is the wrong setup for a levered industrial with limited earnings visibility.

Contrarian view: the market may overreact to the GAAP loss and underweight the balance-sheet de-risking from free cash flow plus buybacks, but that only matters if FCF stays above maintenance capex after the inventory release fades. The thesis is falsified if quarterly adjusted EBITDA re-accelerates back above roughly the low-$70mm run rate with stable pricing, or if management shows the closure package is truly margin-accretive by Q4. Absent that, this looks like a quality trap rather than an undervalued compounder.

Key Decisions for Investors

• Short KOP on any post-earnings bounce; use a 1-3 month horizon and size for catalyst decay as closure costs hit but pricing remains weak. Risk/reward favors the short if adjusted EBITDA stalls below the mid-$70mm quarterly level.
• Pair trade: short KOP / long Stella-Jones (SJ) over the next 1-2 quarters. The cleaner pole/tie exposure and better pricing discipline should outperform if utility-pole demand remains constructive while KOP’s mix remains pressured.
• Set a tactical alert rather than a full position: if KOP’s next quarter shows RUPS price stabilization and adjusted EBITDA margin recovery, cover the short. A sustained margin move back above ~12% in RUPS would invalidate the near-term bear case.
• Watch KOP debt metrics and covenant commentary into the next update. If working-capital inflows normalize and free cash flow drops meaningfully from the current run rate, equity downside risk increases because buybacks become less supportive.